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Why were these guidelines written?
Leptospirosis is a worldwide public health problem. In humid tropical
and subtropical areas, where most developing countries are found, it is a
greater problem than in those with a temperate climate. The magnitude
of the problem in tropical and subtropical regions can be largely attributed
to climatic and environmental conditions but also to the great likelihood
of contact with a Leptospira-contaminated environment caused by, for
example, local agricultural practices and poor housing and waste disposal,
all of which give rise to many sources of infection. In countries with
temperate climates, in addition to locally acquired leptospirosis, the
disease may also be acquired by travellers abroad, and particularly by
those visiting the tropics.
Leptospirosis is a potentially serious but treatable disease. Its
symptoms may mimic those of a number of other unrelated infections
such as influenza, meningitis, hepatitis, dengue or viral haemorrhagic
fevers. Some of these infections, in particular dengue, may give rise to
large epidemics, and cases of leptospirosis that occur during such
epidemics may be overlooked. For this reason, it is important to
distinguish leptospirosis from dengue and viral haemorrhagic fevers,
etc. in patients acquiring infections in countries where these diseases
are endemic. At present, this is still difficult, but new developments may
reduce the technical problems in the near future. It is necessary, therefore,
to increase awareness and knowledge of leptospirosis as a public health
threat. The aim of these guidelines is to assist in this process.
In many respects, leptospirosis may be viewed as an emerging
disease, and this has led to an increased interest and demand for
information, notably in developing countries. New and less complicated
diagnostic methods have been developed in recent years, allowing
leptospiral infection to be identified without the real need for recourse
to specialized reference laboratories.
For whom were they written?
The target group to which these guidelines are directed consists of
health workers (clinicians, laboratory technicians, microbiologists, public
health workers, veterinarians and biologists with an interest in zoonoses,
etc.) having no specialized knowledge of leptospirosis but who wish to
be generally informed about the microorganism concerned and the disease
that it may cause. This is not a handbook and avoids technical detail, but
the interested reader can find further information in the Annexes and the
general bibliography.
Since technical support is least available in many of those countries
where the clinical problems are greatest, the emphasis is on relatively
simple methods, even though some of them are not yet suited to routine
practice. Information on the availability of technical support is provided
in the list of expert centres (Annex 1).
Leptospirosis is a health problem in both human and veterinary
medicine, but these guidelines are concerned essentially with human
leptospirosis. The indispensable role of veterinarians in leptospirosis
control is fully appreciated, but the inclusion of information on veterinary
leptospirosis would overload the general reader. The guidelines take the
form of questions and answers, many of the questions being based on
those put before reference centres over the years.
Future perspectives
Leptospirosis is easily overlooked and relatively little is known about
it. Few studies are therefore carried out on it, and this, in turn, results in
the disease being overlooked. These guidelines aim to increase awareness
of it. Better diagnosis and surveillance programmes may break the vicious
circle.
The guidelines will be updated at regular intervals. The reader is
referred to the Secretary of the International Leptospirosis Society (Annex
1) for further information on the Society and on leptospirosis.
The guidelines were drawn up by a joint team from the World Health
Organization and the International Leptospirosis Society.
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